Reinhard Gabathuler
Keine laufenden Positionen mehr
Profil
Reinhard Gabathuler is the founder of Synapse Technologies, Inc. Prior to that, he worked as Director & Senior VP-Business Development at Nevis Brands, Inc. from 2015 to 2018.
He was also Vice President-Brain Research at BioMarin Pharmaceutical, Inc. and Chief Scientific Officer at Angiochem, Inc. Additionally, he worked as Principal at the University of British Columbia and Ludwig Institute for Cancer Research Ltd.
He holds a doctorate degree from the University of Lausanne, which he received in 1982.
Ehemalige bekannte Positionen von Reinhard Gabathuler
| Unternehmen | Position | Ende |
|---|---|---|
| NEVIS BRANDS INC. | Chief Executive Officer | 08.12.2015 |
| BIOASIS TECHNOLOGIES INC. | Chief Tech/Sci/R&D Officer | 18.09.2017 |
Ludwig Institute for Cancer Research Ltd.
 Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| University of British Columbia | Corporate Officer/Principal | - |
Synapse Technologies, Inc.
 Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Founder | - |
Ausbildung von Reinhard Gabathuler
| University of Lausanne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| BIOASIS TECHNOLOGIES INC. | Health Technology |
| NEVIS BRANDS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Health Technology |
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Ludwig Institute for Cancer Research Ltd.
Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY. | Health Services |
